
Advances in cancer therapy offer new hope, and recent research into treatments like ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203) highlights the ongoing progress in this field. While Melbourne Oral Medicine does not treat esophageal cancer itself, Dr. Suhaib Alqudah, a registered Oral Medicine Specialist, plays a crucial role in providing expert oral health support and care for patients undergoing complex cancer treatments. His expertise includes managing oral complications arising from systemic diseases and their therapies, ensuring patients maintain their oral health and quality of life throughout their cancer journey.
Esophageal squamous cell carcinoma (ESCC) is a type of cancer that develops in the cells lining the oesophagus, the tube that carries food from the throat to the stomach. Common symptoms can include difficulty swallowing (dysphagia), a sensation of food getting stuck, unexplained weight loss, chest pain or discomfort, hoarseness, and a chronic cough. If you experience persistent swallowing difficulties, pain when swallowing, or any unexplained weight loss, these are red flags that warrant prompt medical attention. It is crucial to consult your general practitioner (GP) without delay for an accurate diagnosis and appropriate referral to specialists such as gastroenterologists or oncologists. Early detection and treatment are vital for managing ESCC.
The AdvanTIG-203 study, focusing on novel immunotherapy combinations like ociperlimab and tislelizumab, represents a significant step forward in treating advanced ESCC. These advanced therapies, while offering improved outcomes, can sometimes lead to various side effects, many of which can affect the oral cavity. Dr. Alqudah's background, including his time at the Peter MacCallum Cancer Centre, has equipped him with extensive experience in providing comprehensive dental and oral care for cancer patients and those with medically complex conditions. Managing these oral side effects is essential for patient comfort, nutritional intake, and overall well-being during treatment.
Cancer treatments such as chemotherapy, radiation therapy, and immunotherapy can have profound effects on oral health. An Oral Medicine Specialist focuses on diagnosing and managing these complications. Common oral issues include:
The goal of Oral Medicine in this context is to manage these symptoms, prevent further complications, and improve the patient's overall quality of life, allowing them to better tolerate and continue their primary cancer treatment.
Melbourne Oral Medicine offers secure video (telehealth) consultations Australia-wide, providing convenient access to specialist oral medicine care without the need for travel. This is particularly beneficial for cancer patients who may be immunocompromised, experiencing fatigue, or living in regional areas. During an online assessment, Dr. Alqudah can evaluate persistent mouth ulcers, oral mucosal diseases, dry mouth, altered taste, burning sensations, or jaw pain. He can provide expert triage, offering reassurance, guiding you or your referring GP/dentist on necessary investigations such as blood tests or imaging, and advising on whether a biopsy or in-person referral is required. This remote approach ensures timely specialist input, supports your oncology team, and helps in developing a tailored oral care plan.
The advancements in treatments for conditions like esophageal squamous cell carcinoma offer renewed hope. Complementing these therapies with dedicated oral health support is vital for comprehensive patient care. If you or your patient are experiencing oral health challenges during cancer treatment, or have any concerning oral symptoms, please do not hesitate to reach out for specialist guidance.
Reference: Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203). Nature Communications 17, 7771 (2026). https://www.nature.com/articles/s41467-026-77705-8
Yes, absolutely. An Oral Medicine Specialist, like Dr. Alqudah, focuses on diagnosing and managing oral complications that can arise from cancer and its treatments, such as dry mouth, oral sores, taste changes, and pain. They work to alleviate symptoms, prevent infections, and improve your overall oral health during this critical time.
Common oral side effects include dry mouth (xerostomia), oral mucositis (painful sores), altered taste, burning sensations, increased risk of dental decay and gum disease, and sometimes jaw pain. These can vary depending on the type of cancer, treatment, and individual patient.
Our secure video consultations allow you to receive specialist advice from the comfort of your home, avoiding travel and potential exposure risks. Dr. Alqudah can assess your symptoms, provide a provisional diagnosis, recommend further investigations (like blood tests or imaging), and develop a management plan. He can also coordinate with your oncology team or local dental/medical professionals for seamless care.
#Oralmedicine #Cancercare #Esophagealcancer #Oralhealth #Telehealth #Oralmucositis
Have a question? Our team can help — book a consultation or explore our services. Book a consultation or explore our services.
Add Comment